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Summary.-The clinical features of 19 patients with malignant infiltration of the
retroperitoneal tissues are described. These patients usually presented with
unexplained uraemia and nonspecific symptoms; only a few had other evidence
of malignancy. The diagnosis was resolved only by histological examination of
multiple biopsy specimens. Since the prognosis is usually very poor it is essential
to distinguish this condition from non-malignant causes of retroperitoneal fibrosis.
RETROPERITONEAL fibrosis, or peri-
ureteric fibrosis, was first fully described
by Ormond (1948) and Raper (1956)
although an earlier case report by Albar-
ran (1905) has since been discovered.
Despite various hypotheses the aetiology
of this condition still remains obscure
(Kay, 1963) and only an association with
methysergide has been claimed (Graham
et al., 1966). The term " idiopathic "
helps to distinguish this now well recog-
nized clinical entity from those cases in
which a cause has been established.
Thus, retroperitoneal fibrosis may be
considered in three groups-idiopathic,
non-malignant and malignant. The non-
malignant condition is a benign retro-
peritoneal fibrosis secondary to some
known cause such as aortic or colonic
surgery, radiotherapy or retroperitoneal
infection (Cerny and Scott, 1971). Malig-
nant retroperitoneal fibrosis may be
secondary to a variety ofprimary tumours
including breast, stomach, prostate and
cervix (Ormond, 1960), reticulum cell
sarcoma (Treves, 1958) and Hodgkin's
disease (Nitz et al., 1970). In this paper
wehave examined 19 cases ofhistologically
proven malignant retroperitoneal fibrosis
in order to characterize the clinical
features of a condition in which the
diagnosis is often delayed and the prog-
nosis, though poor, is often uncertain.
Patients
In the 12 year period 1960-72, 35
cases of retroperitoneal fibrosis were
treated in this unit; of these 10 were
idiopathic, 6 non-malignant and 19 malig-
nant. The age of the malignant cases
ranged from 21 to 77 years with a mean
of 54 years; I1 patients were male and
8 female.
The most common presenting symp-
toms were those due to uraemia, particu-
larly anorexia, nausea, vomiting and
lassitude. The other main presenting
symptoms were loin pain, abdominal
pain, dyspepsia and backache (Table I).
With one exception all the patients pre-
sented with or soon developed oliguria
and uraemia. Eight of the 19 patients
were known to have been treated for
malignant disease (Table II) and these
had either an abdominal or mastectomy
scar or terminal colostomy. One patient
was found to have a malignant pleural
effusion on physical examination, another
had an irregular abdominal mass and a
third (with giant follicular lymphoma)
had palpable axillary and supraclavicularM. H. THOMAS AND G. D. CHISHOLM
pancreas, cervix, giant
follicular lymphoma
Colon 2, breast, pancreas
Lymphosarcoma 2, ovary
Stomach, pancreas
Renal pelvis, reticulum
cell sarcoma*
* Non-uraemic.
TABLE 1I.-Malignant Retroperitoneal
Fibrosis: Proportion of Patients Known
to have had Treated Malignant Disease
Known
Primary tumour malignant dlisease Total
Colon and rectum 5 6
Reticuloses 0 4
(lymphosarcoma 2,
giant follicular
lymphoma, reticulum
cell sarcoma)
Pancreas
Breast
Renal pelvis
Cervix uteri
Stomach
Ovary
Totals
0
2
0
1
0
8
3
2
1
1
1
1
19
lymph nodes. However, clinical examina-
tion of these patients did not often prove
helpful in establishing the main diagnosis.
The blood urea concentration on
admission was markedly raised in 18 cases
and ranged from 200 mg/100 ml to 470
mg/100 ml, with a mean of 316 mg/O00
ml; in one case it was 23 mg/100 ml.
The erythrocyte sedimentation rate (ESR)
was raised in the 8 cases in which it was
recorded. Two cases had an ESR in
excess of 100 mm in one hour (Westergren
method). Only 2 patients were not
anaemic, all the others having a haemo-
globin level of less than 10-0 g/l00 ml.
No patients showed a leucoerythroblastic
blood film. Abnormal liver function,
manifest as a raised alkaline phosphatase
and 5' nucleotidase value, was found in
only one case. All the patients under-
went x-ray examination of the chest and
abdomen. Chest x-ray revealed a malig-
nant pleural effusion in one case. Plain
x-ray of the abdomen was not helpful
in the diagnosis of retroperitoneal fibrosis,
although in one patient fluid levels of
subacute small bowel obstruction (due
to reticulum cell sarcomatous masses)
were seen.
Twelve of the 19 patients underwent
cystoscopy and ureteric catheterization.
At all these examinations the ureteric
catheter passed easily up one and often
both ureters; when there was an obstruc-
tion to the catheter a bulb uretero-
pyelogram was carried out. Of the 7
who did not have this investigation, 4 had
been previously diagnosed at laparotomy,
one had a uretero-colic anastomosis, one
had an ileal conduit and one was too ill
for further investigation. The non-urae-
mic patient developed bilateral ankle
oedema and was the only patient to
undergo inferior vena cavography. This
showed occlusion of the inferior vena
cava with multiple lumbar collateral
vessels. Lymphangiography was not per-
formed in any ofthe patients in this series.
Treatment
Dialysis.-7 patients required dialysis:
3 had peritoneal dialysis, 2 had haemo-
dialysis and 2 were treated by both
forms of dialysis.
Operation. 4 patients underwent diag-
nostic laparotomy. Two had no further
procedure because of the extent of the
disease; 1 had a uretero-ureterostomy at
the time and had had a ureterostomy
performed 2 weeks before the laparotomy.
Biopsies were taken at each operation
from the fibrous tissue surrounding the
ureters and any other suspicious tissue
or enlarged lymph nodes. An operative
procedure to relieve urinary obstruction
was undertaken in 9 patients (Table III).
Other methods.-The non-uraemic
patient had a reticulum cell sarcoma and
was given 3 courses of cyclophosphamide
and vincristine, to which he made a
dramatic response. He was the only
patient successfully treated with chemo-
TABLE I.-Clinical Presentation and Site
of Primary Tumour in 19 Patients with
JMalignant Retroperitoneal Fibrosis
Main presenting
symptom Number Primary tumour
Uraemia 8 Colon 2, rectum 2, breast,
Loin pain
Abdominal pain
Dyspepsia
Backache
4
3
2
2
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TABLE III. Malignant Retroperitoneal
Fibrosis: Operative Procedures
Operation Number
Laparotomy 3
Pyelostomy 3
Ureterostomy 3
Laparotomy and uretero-ureterostomy 1
(previous uretero-colic anastomosis)
Ureteroileostomy (previous ileal conduit) 1
Ureterolysis 1
Total 12
therapy and has continued on combina-
tion therapy (cyclophosphamide, vin-
cristine, procarbazine, prednisone) under
the care of Dr L. Szur. Another patient,
with giant follicular lymphoma, was
given melphalan but died within 10 days
from bronchopneumonia. None of the
patients received radiotherapy.
Pathology
The primary tumours are listed in
Table 1. The macroscopic appearance
of the retroperitoneal fibrosis tissue at
operation was never obviously malignant
and in several cases the appearances
closely resembled idiopathic retroperi-
toneal fibrosis. The diagnosis in these
doubtful cases was made from the
histology of the biopsy specimen.
The microscopic appearances showed
dense collagen tissue infiltrated with
chronic inflammatory cells and nests of
malignant cells (Fig. 1, 2, 3). Aggregates
or sheets of malignant cells were seen in
some cases and usually showed sufficient
differentiation to diagnose or confirm the
diagnosis of the primary lesion. In some
cases further confirmation of the malig-
nant process was made from the involved
lymph nodes, which showed either second-
ary carcinoma or lymphomatous change.
There were 4 patients with reticuloses.
The extent of the tumour in both patients
FiG. 1. Malignant retroperitoneal fibrosis: primary tumour squamous carcinoma ofrenal pelvis.
H. and E. x 200.FIG. 2. Fibrous tissue diffusely infiltrated by a moderately well differentiated adenocarcinoma;
primary tumour carcinoma of colon. H. and E. x 200.
iIG. 3.-viallignant retroperitoneal fibrosis. Primary tumour- carcinoma head of pancreas.
H. and E. x 200.RETROPERITONEAL FIBROSIS ASSOCIATED WITH MALIGNANT DISEASE 457
with lymphosarcoma, as well as in the
patient with a reticulum cell sarcoma,
was confined to the peritoneum. The
patient with giant follicular lymphoma
had tumour involvement of peripheral
lymph nodes and vertebral bodies as
well as diffuse retroperitoneal infiltration.
DISCUSSION
The mean age of the patients in this
series was 54 years, compared with a
mean age of 44 years in the series with
non-malignant retroperitoneal fibrosis re-
ported by Webb and Dawson-Edwards
(1967b). Malignant retroperitoneal fibro-
sis appears to occur with about equal
frequency in men and women. In review-
ing a series of 95 patients with idiopathic
retroperitoneal fibrosis, Ormond (1960)
observed that men were affected twice as
often as women.
The distinction between the three
groups of retroperitoneal fibrosis may be
difficult. The history, clinical examina-
tion, radiological findings and even the
macroscopic appearances at laparotomy
may not distinguish the benign from the
malignant type. Histology from an oper-
ative specimen is always needed to
confirm the diagnosis and this applies as
much to those where the fibrosis is
thought to be benign as to those likely to
be malignant.
A previous history of malignancy is
helpful and half of the patients in this
series were known to have been treated
for malignancy when they first presented.
Abnormal liver function was found in
only one case; this patient had a squamous
cell carcinoma of the renal pelvis. Liver
function may be disturbed if there are
hepatic secondaries or if the patient has
received cytotoxic therapy, while a pri-
mary renal carcinoma may also affect
liver function (Chisholm and Roy, 1971).
It is evident from this, and other reported
series of retroperitoneal fibrosis associated
with malignant disease, that no one type
of tumour has a particular predisposition
to the development of retroperitoneal
spread. In this series obstruction to
the lower ureter due to local spread, as
from carcinoma of bladder, has been
excluded and none of the patients had
received radiotherapy.
Retrograde uretero-pyelography re-
mains an essential step in the investiga-
tion of obstructive uropathy. In patients
who have had a previous urinary diversion,
a high dose intravenous pyelogram or
an antegrade pyelogram can be useful
(Sherwood and Stevenson, 1972). Idio-
pathic retroperitoneal fibrosis produces
characteristic radiological features and
can usually be recognized (Dineen, Asch
and Pearce, 1960). However, the dis-
tinction between the benign and malignant
causes of fibrosis was not often possible
from pyelographic appearances in this
series. Lymphangiography and inferior
vena cavography have been used in the
investigation of such cases (Clouse, Fraley
and Litwin 1964), but only occasionally
has lymphangiography been useful in
separating benign from malignant retro-
peritoneal fibrosis (Webb and Dawson-
Edwards 1967a).
Dialysis is mandatory in the un-
diagnosed uraemic patient so that the
primary cause may be sought and a fill
assessment made.
Laparotomy may be undertaken as a
diagnostic measure and may proceed to
a palliative operation to relieve the
urinary obstruction. At operation meta-
static spread in the retroperitoneum may
be obvious; however, since it is usually
difficult to distinguish the gross appear-
ance of benign retroperitoneal fibrosis
from the malignant variety, it is essential
to take multiple and deep biopsies.
Discrete nodal masses or secondary de-
posits should be biopsied. It is possible
in a plaque of malignant retroperitoneal
fibrosis to miss an area of malignant
cells, thus emphasizing the need for
multiple biopsies. Because ofthe import-
ance of a tissue diagnosis in the manage-
ment of retroperitoneal fibrosis, we would
recommend that all cases should have a
biopsy of the retroperitoneal tissues,
especially before embarking on treatment458 M. H. THOMAS AND G. D. CHISHOLM
of the idiopathic variety with steroids
(Charlton, 1968).
Whether urinary obstruction with
uraemia should be relieved in a patient
with malignant disease is still a question
for clinical judgment in the individual
case. Indications for palliative inter-
ference are probably few as the results
are so poor. A surgical procedure was
considered justified in 9 of the 19 patients
and of these, 2 had an acceptable result
in terms of length and quality of survival.
All those not considered suitable for
relief of obstruction died within 4 weeks.
In a study of malignant obstruction with
uraemia, the six-month survival for car-
cinoma ofthe bladder was 30%0, carcinoma
of the cervix 20%, and carcinoma of the
prostate 50%0 (Chisholm and Shackman,
1968). The comparable figure in the
present series with malignant retroperi-
toneal fibrosis was 10%.
We wish to thank Dr J. G. Azzopardi
and Dr I. D. Ansell for their advice on
the histological sections, the Department
of Medical Illustration for the figures
and Dr L. Szur for his comments on those
patients with reticuloses.
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